| | | Cancer drug shows promise as COVID-19 treatment | | IMI project IMPENTRI’s trial of cancer drug imatinib has shown promising results (lower mortality, shorter ventilation, better outcomes) after 90 days, confirming its benefits in severe COVID-19 cases. | | |
|
| | | COVID CARE: antibody mapping detects vulnerable spike sites, and another promising antiviral emerges | | The IMI-funded CARE project helps speed up antibody drug discovery while opening a promising new avenue for antiviral research to tackle COVID-19. | | |
|
|
|
|
|
|
|
|
|
